Virtual Event Coverage

32nd Annual ROTH Conference

March 15-17, 2020 - Ritz Carlton, Dana Point, CA
Presenting Companies: A - E F - J K - O P - T U - Z

KalVista Pharmaceuticals Inc. (NASDAQ: KALV)

KalVista Pharmaceuticals (NASDAQ: KALV) is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body's inflammatory response and which, in excess, can lead to increased vascular permeability, edema and inflammation. KalVista has developed a proprietary portfolio of novel, small molecule plasma kallikrein inhibitors initially targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The company has created a structurally diverse portfolio of oral plasma kallikrein inhibitors and is advancing multiple drug candidates for HAE as well as DME. For more information, visit the company's website at www.kalvista.com

Kits.com

Kits.com (PRIVATE) is one of the world's leading and fastest growing contact lens companies on the Internet. With over 50 million lenses sold since 2004, the consumer can rest assured that they are are buying contacts and glasses from a reputable and reliable source, for a fraction of the cost paid at a doctor's office. The Kits.com leadership team has over 70 years of combined experience providing contact lenses to tens of millions of customers in North America and is using that experience to build KITS, the world's best eyecare company for customers. For more information, visit the company's website at www.kits.com

Knowles Corporation (NYSE: KN)

Knowles (NYSE: KN) is a market leader and global provider of advanced micro-acoustic, audio processing, and precision device solutions, serving the mobile consumer electronics, communications, medical, defense, automotive and industrial markets. Knowles uses its leading position in MEMS (micro-electro-mechanical systems) microphones and strong capabilities in audio processing technologies to optimize audio systems and improve the user experience in mobile, ear and IoT applications. Knowles is also the leader in acoustic components, high-end capacitors, and mmWave RF solutions for a diverse set of markets. Knowles' focus on the customer, combined with unique technology, proprietary manufacturing techniques, rigorous testing, and global scale, enables it to deliver innovative solutions that optimize the user experience. For more information, visit the company's website at www.knowles.com

KushCo Holdings Inc. (OTCQX: KSHB)

KushCo Holdings (OTCQX: KSHB) is a premier producer of ancillary products and services to the legal cannabis and CBD industries. KushCo Holdings' subsidiaries and brands provide product quality, exceptional customer service, compliance knowledge and a local presence in serving its diverse customer base. Founded in 2010, KushCo Holdings has now sold more than 1 billion units to growers, processors and producers across North America, South America and Europe. While KushCo Holdings provides products and solutions to customers in the cannabis and CBD industries, it has no direct involvement with the cannabis plant or any products that contain THC. For more information, visit the company's website at www.kushco.com

Kuuhubb Inc. (TSXV: KUU)

Kuuhubb (TSXV: KUU) is a mobile game development and publishing company focused on providing the female audience with creative interactive gaming experiences. Kuuhub creates games and apps that help its audience relax, express, and entertain themselves every day. Kuuhuub explores new lifestyle trends that can be converted into apps and games and offers its audience unforgettable gaming and esports experiences. For more information, visit the company's website at www.kuuhubb.com

Lakeland Industries Inc. (NASDAQ: LAKE)

Lakeland Industries (NASDAQ: LAKE) is a global leader in the manufacturing of protective clothing to help improve the quality of safety for the industrial workforce including electric and gas utilities, petrochemical, hazardous waste sites, chemical handling, cleanrooms, fire services and road crews, to name a few. Backed by over 35 years of time-tested, high-performance workwear, the company helps empower customers to provide the safest working environment possible. For more information, visit the company's website at www.lakeland.com

Landec Corp. (NASDAQ: LNDC)

Landec (NASDAQ: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods Inc. and Lifecore Biomedical Inc. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods maximizes product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information, visit the company's website at www.landec.com

Landos Biopharma Inc.

Landos Biopharma (PRIVATE) is committed to the discovery and development of first-in-class, oral therapeutics for patients with autoimmune diseases. The company's lead product candidate, BT-11, is a small molecule targeting Lanthionine Synthetase C-Like 2 (LANCL2), a pathway designed to limit its impact to the gastrointestinal tract. The company is evaluating BT-11 in a phase 2 ulcerative colitis (UC) study and is planning a phase 2 Crohn's disease (CD) study to begin in 2020. The company's pipeline is composed of innovative compounds targeting two novel pathways identified using computational pathway modeling. The Landos vision is to ultimately deliver safer, more effective treatments for patients with IBD. For more information, visit the company's website at www.landosbiopharma.com

Lannett Company Inc. (NYSE: LCI)

Lannett Company (NYSE: LCI) is a leading manufacturer of over 100 unique pharmaceutical product families that save and enhance people's lives. Lannet develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. Lannet is a US-based, with headquarters in Philadelphia, PA, and top-notch facilities for research and development, manufacturing, packaging, business, and distribution in three states including Pennsylvania, Indiana, and New York. For more information, visit the company's website at www.lannett.com

Lantronix Inc. (NASDAQ: LTRX)

Lantronix (NASDAQ: LTRX) is a global provider of secure data access and management solutions for Internet of Things (IoT) assets. Lantronix's mission is to be the leading supplier of IoT solutions that enable companies to dramatically simplify the creation, deployment, and management of IoT projects while providing secure access to data for applications and people. With more than two decades of experience in creating robust machine to machine (M2M) technologies, Lantronix is an innovator in enabling customers to build new business models and realize the possibilities of the Internet of Things. For more information, visit the company's website at www.lantronix.com

LeMaitre Vascular Inc. (NASDAQ: LMAT)

LeMaitre Vascular (NASDAQ: LMAT) is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. For more information, visit the company's website at www.lemaitre.com

LifeVantage Corp. (NASDAQ: LFVN)

LifeVantage (NASDAQ: LFVN) is a pioneer in nutrigenomics, a new science dedicated to biohacking the human aging code. LifeVantage engages in the identification, research, development and distribution of advanced nutrigenomic dietary supplements and skin and hair care products, including its scientifically validated Protandim® product line, Omega+ and ProBio dietary supplements, its TrueScience® line of Nrf2-infused skin and hair care products, Petandim™ for Dogs, Axio® Smart Energy Drink mixes, and the PhysIQ™ Smart Weight Management System. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah. For more information, visit the company's website at www.lifevantage.com

Ligand Pharmaceuticals Inc. (NASDAQ: LGND)

Ligand Pharmaceuticals (NASDAQ: LGND) is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand's business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand has established multiple alliances, licenses and other business relationships with the world's leading pharmaceutical companies including Amgen, Merck, Pfizer, Sanofi, Janssen, Takeda, Baxter International and Eli Lilly. For more information, please visit the company's website at www.ligand.com

Limbach Holdings Inc. (NASDAQ: LMB)

Limbach Holdings (NASDAQ: LMB) is the ninth largest mechanical systems solutions firm in the United States, as determined by Engineering News Record. Limbach provides building infrastructure services, with an expertise in the design, installation and maintenance of HVAC and mechanical, electrical, and plumbing systems for a diversified group of commercial and institutional building owners. Limbach employs more than 1,700 employees in 14 offices throughout the United States. The company's full life-cycle capabilities, from concept design and engineering through system commissioning and recurring 24/7 service and maintenance, position Limbach as a value-added and essential partner for building owners, construction managers, general contractors and energy service companies. For more information, visit the company's website at www.limbachinc.com

Limoneira Company (NASDAQ: LMNR)

Limoneira Company (NASDAQ: LMNR) is a 126-year-old international agribusiness headquartered in Santa Paula, California, that has grown to become one of the premier integrated agribusinesses in the world. Limoneira is a dedicated sustainability company with 15,700 acres of rich agricultural lands, real estate properties, and water rights in California, Arizona, Chile and Argentina. The company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more information, visit the company's website at www.limoneira.com

Lindblad Expeditions Holdings Inc. (NASDAQ: LIND)

Lindblad Expeditions (NASDAQ: LIND) is an expedition travel company that works in partnership with National Geographic to inspire people to explore and care about the planet. The organizations work in tandem to produce innovative marine expedition programs and to promote conservation and sustainable tourism around the world. The partnership's educationally oriented voyages allow guests to interact with and learn from leading scientists, naturalists and researchers while discovering stunning natural environments, above and below the sea, through state-of-the-art exploration tools. For more information, visit the company's website at www.expeditions.com

Lipidio Pharmaceuticals Inc.

Lipidio Pharmaceuticals (PRIVATE) is focused on advancing a molecule to treat diseases associated with excess body fat including non-alcoholic steatohepatitis (NASH), Prader-Willi syndrome (PWS) and antipsychotic drug-induced weight gain (AIWG), which represent major unmet medical needs. Lipidio acquires molecules that b it believes have unrealized therapeutic potential then applies unique in-house expertise to optimize each molecules' preclinical and clinical development plans to enable marketing approval and/or a successful exit. The company leverages the proven drug development track record of its team to identify, develop and transform molecules into important medicines. For more information, visit the company's website at www.lipidiopharma.com

Lipocine Inc. (NASDAQ: LPCN)

Lipocine (LPCN) is a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders using its proprietary drug delivery technologies. Lipocine's clinical development pipeline includes TLANDO XR, a novel oral prodrug of testosterone, originated and being developed by Lipocine as a next-generation oral testosterone product. In a phase 2 clinical evaluation when administered as once daily or twice daily TLANDO XR met the typical primary and secondary end points. LPCN 1148 is an oral prodrug of bioidentical testosterone targeted for the treatment of NASH cirrhosis. LPCN 1107 is potentially the first oral hydroxyprogesterone caproate product candidate, with end of phase 2 meeting completed, indicated for the prevention of recurrent preterm birth and has been granted orphan drug designation by the FDA. For more information, visit the company's website at www.lipocine.com

LiqTech International Inc. (NASDAQ: LIQT)

LiqTech International (NASDAQ: LIQT) is a clean technology company that provides state-of-the-art ceramic silicon carbide filtration technologies for gas and liquid purification. LiqTech's silicon carbide membranes are designed to be used in the most challenging water purification applications and its silicon carbide filters are used to control diesel exhaust soot emissions. Using nanotechnology, LiqTech develops products using its proprietary silicon carbide technology, resulting in a wide range of component membranes, membrane systems and filters for both microfiltration and ultrafiltration applications. By incorporating LiqTech's SiC liquid membrane technology with the company's extensive systems design experience and capabilities, LiqTech offers unique, turnkey solutions for the most difficult water purification applications. For more information, visit the company's website at www.liqtech.com

Lithium Americas Corp. (TSX: LAC) (NYSE: LAC)

Lithium Americas (TSX: LAC) (NYSE: LAC) owns a 50% interest in the Caucharí-Olaroz lithium project under construction in Jujuy, Argentina. Lithium Americas through a wholly owned subsidiary, Lithium Nevada, owns 100% of the Thacker Pass lithium project located in Nevada and the largest known lithium deposit in the United States. For more information, visit the company's website at www.lithiumamericas.com

LivePerson Inc. (NASDAQ: LPSN)

LivePerson (NASDAQ: LPSN) aims to make life easier by transforming how people communicate with brands. LivePerson's 18,000 customers, including leading brands like Citibank, HSBC, Orange and The Home Depot, use the company's conversational commerce solutions to orchestrate humans and AI, at scale, and create a convenient, deeply personal relationship — a conversational relationship — with their millions of consumers. For more information, visit the company's website at www.liveperson.com

LiveXLive Media Inc. (NASDAQ: LIVX)

LiveXLive Media (NASDAQ: LIVX) is a global digital media company focused on live entertainment. The company operates LiveXLive, the first 'live social music network,' delivering premium livestreams, digital audio and on-demand music experiences from the world's top music festivals and concerts, including Rock in Rio, EDC Las Vegas, the Montreux Jazz Festival, and many others. LiveXLive also gives audiences access to premium original content, artist exclusives and industry interviews. For more information, visit the company's website at www.livexlive.com

Lonestar Resources US Inc. (NASDAQ: LONE)

Lonestar Resources US (NASDAQ: LONE) is focused on the volatile crude oil window of the Eagle Ford Shale, where the company anticipates spending most of its capital for the next several years. Lonestar "went public" through a merger with Amadeus Energy, Ltd. on January 2, 2013, to better position the company to pursue its core strategy of growing its leasehold position (currently in excess of 57,000 net acres), production, cash flow and reserve base in one of the most active onshore basins in the U.S. For more information, visit the company's website at www.lonestarresources.com

Loop Industries Inc. (NASDAQ: LOOP)

Loop Industries (NASDAQ: LOOP) is a technology company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. Loop's patented and proprietary technology decouples plastic from fossil fuels by depolymerizing waste plastic and polyester fiber to its base building blocks (monomers). The monomers are then filtered, purified and repolymerized to create virgin quality polyester plastic suitable for use in in food grade packaging. For more information, visit the company's website at www.loopindustries.com

LSI Industries Inc. (NASDAQ: LYTS)

LSI Industries (NASDAQ: LYTS) is a U.S.-based manufacturer of lighting, graphics and technology solutions for both indoor and outdoor applications. LSI is a leading solutions provider to several primary end-markets, including petroleum, automotive, quick serve restaurants, grocery, banking, retail, renovation, parking and warehousing. LSI's products are marketed throughout North America through a network of independent sales representatives and distributors, as well as through national accounts. LSI partners with customers to provide a full range of design support, engineering, installation and project management services. LSI currently employs over 1,200 employees and operates seven facilities throughout the United States. For more information, visit the company's website at www.lsi-industries.com

Luna Innovations Inc. (NASDAQ: LUNA)

Luna Innovations (NASDAQ: LUNA) is a leader in optical technology, providing unique capabilities in high-performance, fiber optic-based, test products for the telecommunications industry and distributed fiber optic-based sensing for the aerospace and automotive industries. Luna is organized into two business segments – Technology Development and Products and Licensing - which work closely together to turn ideas into products. Luna's business model is designed to accelerate the process of bringing new and innovative technologies to market. For more information, visit the company's website at www.lunainc.com

Luxfer Holdings PLC (NYSE: LXFR)

Luxfer Holdings (NYSE: LXFR) is a global manufacturer of highly engineered industrial materials, which focuses on value creation by using its broad array of technical knowhow and proprietary technologies. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense and emergency response, health care, transportation and general industrial applications. For more information, visit the company's website at www.luxfer.com

MAG Silver Corp. (TSXV: MAG) (NYSE: MVG)

MAG Silver (TSXV: MAG) (NYSE: MVG) is focused on district scale projects located within the Mexican Silver Belt. The company mission is to become one of the premier companies in the Silver Mining Industry. MAG and its partner Industrias Peñoles are delineating a significant new silver vein deposit on the Juanicipio Joint Venture in Zacatecas State, Mexico. MAG is based in Vancouver, British Columbia, Canada. For more information, visit the company's website at www.magsilver.com

MagnaChip Semiconductor Corp. (NYSE: MX)

MagnaChip Semiconductor (NYSE: MX) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT, consumer, industrial and automotive applications. The company's Standard Products Group and Foundry Services Group provide a broad range of standard products and manufacturing services to customers worldwide. MagnaChip, with about 40 years of operating history, owns a portfolio of approximately 3,000 registered patents and pending applications, and has extensive engineering, design and manufacturing process expertise. For more information, visit the company's website at www.magnachip.com

Manitex International Inc. (NASDAQ: MNTX)

Manitex International (NASDAQ: MNTX) is a leading worldwide provider of highly engineered mobile cranes (truck mounted straight-mast and knuckle boom cranes, industrial cranes, rough terrain cranes and railroad cranes), truck mounted aerial work platforms and specialized industrial equipment. The company's products, manufactured in facilities in the USA and Europe, are targeted to selected niche markets where their unique designs and engineering excellence fill the needs of customers and provide a competitive advantage. Manitex has consistently added to its portfolio of branded products and equipment both through internal development and focused acquisitions to diversify and expand sales and profit base. For more information, visit the company's website at www.manitexinternational.com

Marchex Inc. (NASDAQ: MCHX)

Marchex (NASDAQ: MCHX) is a leading provider of call analytics that drive, measure and convert callers into customers. Marchex provides solutions that help companies drive more calls, understand what happens on those calls, and convert more of those callers into customers. The Marchex's actionable intelligence strengthens the connection between companies and their customers, bridging the physical and digital world, to help brands maximize their marketing investments and operating efficiencies to acquire the best customers. For more information, visit the company's website at www.marchex.com

Marker Therapeutics Inc. (NSDAQ: MRKR)

Marker Therapeutics (NASDAQ: MRKR) is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Because Marker does not genetically engineer its T cell therapies, the company believes its product candidates will be easier and less expensive to manufacture, with reduced toxicities, compared to current engineered CAR-T and TCR-based approaches, and may provide patients with meaningful clinical benefit. For more information, visit the company's website at www.markertherapeutics.com

Mastech Digital Inc. (NYSE: MHH)

Mastech Digital (NYSE: MHH) is a leading provider of Digital Transformation IT Services. Mastech helps clients accelerate business velocity, minimize costs and drastically improve corporate resiliency through the application of data and analytics expertise across three key practice areas: Data Management, Data Engineering and Data Science. The company offers Data Management and Analytics Solutions, Digital Learning and IT Staffing Services with a Digital First approach. A minority-owned enterprise, Mastech Digital is headquartered in Pittsburgh, PA, with offices across the U.S., Canada and India. For more information, visit the company's website at www.mastechdigital.com

Matinas BioPharma Holdings Inc. (NYSE: MTNB)

Matinas BioPharma Holdings (NYSE: MTNB) is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Company leadership has a deep history and knowledge of cardiovascular drug development and is supported by a world-class team of scientific advisors. Matinas is also developing MAT2203, an oral, encochleated formulation of amphotericin B, to treat serious invasive fungal infections. For more information, visit the company's website at www.matinasbiopharma.com

MaxLinear Inc. (NYSE: MXL)

MaxLinear (NYSE: MXL) is a leading provider of radio frequency (RF), analog and mixed-signal integrated circuits for the connected home, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear delivers high-performance broadband and networking semiconductors based on its highly integrated radio frequency analog technology, high-performance optical networking technology and its pioneering MoCA and Direct Broadcast Satellite ODU single-wire technology. Founded in 2003, the company's original high performance, radio-frequency receiver products capture and process digital and analog broadband signals for applications including terrestrial, cable and satellite television and DOCSIS broadband. These products include both RF receivers and RF receiver systems-on-chip, or SoCs, which incorporate highly integrated radio system architecture and demodulator technology. For more information, visit the company's website at www.maxlinear.com

Medallia Inc. (NYSE: MDLA)

Medallia (NYSE: MDLA) is a pioneer and market leader in experience management. Medallia's award-winning SaaS platform, the Medallia Experience Cloud, leads the market in the understanding and management of experience for customers, employees and citizens. Medallia captures experience signals created on daily journeys in person, digital and IoT interactions and applies proprietary AI technology to reveal personalized and predictive insights that can drive action with tremendous business results. Using Medallia Experience Cloud, customers can reduce churn, turn detractors into promoters and buyers, and create in-the-moment cross-sell and up-sell opportunities, providing clear and potent returns on investment. For more information, visit the company's website at www.medallia.com

Medicine Man Technologies Inc. (OTCQX: MDCL)

Medicine Man Technologies (OTCQX: MDCL) is a rapidly growing provider of cannabis consulting services, nutrients, and supplies. The company's client portfolio includes active and past clients throughout the cannabis industry in 20 states and seven countries. The company has entered into agreements to become one of the largest vertically integrated seed-to-sale operators in the global cannabis industry. Current agreements will enable Medicine Man Technologies to offer cultivation, extraction, distribution and retail pharma-grade products. Management includes decades of cannabis experience, a unique combination of first movers in industrial cannabis and proven Fortune 500 corporate executives. For more information, visit the company's website at www.medicinemantechnologies.com

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ)

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a GMP-certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, develops, processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. For more information, visit the company's website at www.medipharmlabs.com

MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF)

MedMen Enterprises (CSE: MMEN) (OTCQX: MMNFF) is North America's premium cannabis retailer. Founders Adam Bierman and Andrew Modlin have defined the next generation discovery platform for cannabis and all its benefits. A robust selection of high-quality products, including MedMen-owned brands, LuxLyte and MedMen Red, coupled with a team of cannabis-educated associates cement the company's commitment to providing an unparalleled experience. MedMen's industry-leading technology enables a fully compliant, owned-and-operated delivery service and MedMen Buds, a nationwide loyalty program. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. For more information, visit the company's website at www.MedMen.com

MGM Resorts International (NYSE: MGM)

MGM Resorts International (NYSE: MGM) is a global entertainment company with national and international locations featuring best-in-class hotels and casinos, state-of-the-art meetings and conference spaces, live and theatrical entertainment experiences, and an extensive array of restaurant, nightlife and retail offerings. The MGM Resorts portfolio encompasses 30 unique hotel and destination gaming offerings including some of the most recognizable resort brands in the industry. MGM has continued expansion throughout the U.S. and around the world. The 83,000 global employees of MGM Resorts are proud of their company for being recognized as one of FORTUNE Magazine's World's Most Admired Companies. For more information, visit the company's website at www.mgmresorts.com

Milestone Scientific Inc. (NYSE: MLSS)

Milestone Scientific (NYSE: MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology platform advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information, visit the company's website at www.milestonescientific.com

Millendo Therapeutics Inc. (NASDAQ: MLND MLND)

Millendo Therapeutics (NASDAQ: MLND) is a late-stage biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. As a leading orphan endocrine company, Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need. The company is currently advancing livoletide for the treatment of Prader-Willi syndrome; nevanimibe for the treatment of classic congenital adrenal hyperplasia; and MLE-301 for the treatment of vasomotor symptoms associated with menopause. For more information, visit the company's website at www.millendo.com

Minera Alamos Inc. (TSXV: MAI) (OTC: MAIFF)

Minera Alamos (TSXV: MAI) (OTC: MAIFF) is a development-stage company with a portfolio of high-quality Mexican assets, including the La Fortuna open-pit gold project in Durango (positive PEA completed and change of land use permit granted) and the Santana open-pit heap-leach development project in Sonora (permits received and construction currently underway). The company's strategy is to develop low capex assets while expanding the project resources and pursue complementary strategic acquisitions. For more information, visit the company's website at www.mineraalamos.com

Mirum Pharmaceuticals Inc. (NASDAQ: MIRM)

Mirum Pharmaceuticals (NASDAQ: MIRM) is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). For more information, visit the company's website at www.MirumPharma.com

Mistras Group Inc. (NYSE: MG)

Mistras Group (NYSE: MG) is a leading "one source" global provider of technology-enabled asset protection solutions used to maximize the uptime and safety of critical energy, industrial, and public infrastructure. MISTRAS combines industry-leading services, systems and technologies to provide a unique, custom-tailored solution for each customer's individual asset protection need. For more information, visit the company's website at www.mistrasgroup.com

Mitek Systems Inc. (NASDAQ: MITK)

Mitek Systems (NASDAQ: MITK) is a global leader in mobile capture and digital identity verification solutions built on the latest advancements in AI and machine learning. Mitek's identity verification solutions enable an enterprise to verify a user's identity during a digital transaction, which assists financial institutions, payments companies and other businesses operating in highly regulated markets in mitigating financial risk and meeting regulatory requirements while increasing revenue from digital channels. Mitek's innovative solutions are embedded into the apps of more than 6,500 organizations and used by more than 80 million consumers for mobile check deposit, new account opening and more. For more information, visit the company's website at www.miteksystems.com

MobileIron Inc. (NASDAQ: MOBL)

MobileIron (NASDAQ: MOBL) is redefining enterprise security with its mobile-centric, zero trust platform built on the foundation of unified endpoint management (UEM) to secure access and protect data across the perimeter-less enterprise. Zero trust assumes that bad actors are already in the network and secure access is determined by a "never trust, always verify" approach. MobileIron goes beyond identity management and gateway approaches by utilizing a more comprehensive set of attributes before granting access. A mobile-centric, zero trust approach validates the device, establishes user context, checks app authorization, verifies the network, and detects and remediates threats before granting secure access to a device or user. For more information, visit the company's website at www.mobileiron.com

Modular Medical Inc. (OTC: MODD)

Modular Medical (OTC: MODD) provides medication delivery technology. The company offers a device that removes the burden of daily injections. Modular Medical serves customers in the United States. For more information, visit the company's website at www.modular-medical.com

Mohawk Group Holdings Inc. (NASDAQ: MWK)

Mohawk Group Holdings (NASDAQ: MWK) is a rapidly growing technology-enabled consumer products company that uses machine learning, natural language processing, and data analytics to design, develop, market and sell products. Mohawk predominantly operates through online retail channels such as Amazon and Walmart. Mohawk has incubated and grouped four owned and operated brands: hOme, Vremi, Xtava and RIF6. Mohawk sells products in multiple categories, including home and kitchen appliances, kitchenware, environmental appliances (i.e., dehumidifiers and air conditioners, beauty-related products and, to a lesser extent, consumer electronics. Mohawk applies artificial intelligence and machine learning to validate high caliber product offerings as opposed to over-reliance on brand value and other traditional marketing tactics. For more information, visit the company's website at www.mohawkgp.com

Moleculin Biotech Inc. (NASDAQ: MBRX)

Moleculin Biotech (NASDAQ: MBRX) is a clinical-stage pharmaceutical company focused on the development of a broad portfolio of oncology drug candidates for the treatment of highly resistant tumors. The company's clinical stage drugs are: Annamycin, a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity, being studied for the treatment of relapsed or refractory acute myeloid leukemia (AML); WP1066, an immune/transcription modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, under investigation for brain tumors, pancreatic cancer and hematologic malignancies; and WP1220, an analog to WP1066, being developed for the topical treatment of cutaneous T-cell lymphoma. For more information, visit the company's website at www.moleculin.com

Monaker Group Inc. (NASDAQ: MKGI)

Monaker Group (NASDAQ: MKGI) is a technology-driven travel company focused on delivering innovation to the alternative lodging rental (ALR) market. The proprietary Monaker Booking Engine (MBE) provides access to more than 2.6 million instantly bookable vacation rental homes, villas, chalets, apartments, condos, resort residences and castles. MBE offers travel distributors and agencies an industry first: a customizable, instant-booking platform for alternative lodging rental. For more information, visit the company's website at www.monakergroup.com

Monarch Casino & Resort Inc. (NASDAQ: MCRI)

Monarch Casino & Resort (NASDAQ: MCRI) through its subsidiaries, owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Casino Black Hawk in Black Hawk, Colorado, approximately 40 miles west of Denver. For more information, visit the company's website at www.monarchcasino.com

Montage Resources Corp. (NYSE: MR)

Montage Resources (NYSE: MR) is an exploration and production company with approximately 218,000 net effective undeveloped acres currently focused on the Utica and Marcellus Shales of southeast Ohio, West Virginia and North Central Pennsylvania. For more information, visit the company's website at www.montageresources.com

MoSys Inc. (NASDAQ: MOSY)

MoSys (NASDAQ: MOSY) is a provider of semiconductor solutions that enable fast, intelligent data access for cloud networking, security, test and video systems. The company's solutions eliminate data access bottlenecks to deliver speed and intelligence for line cards and systems scaling from 100G to multi-terabits per second. Engineered and built for high-reliability carrier and enterprise applications, MoSys' Accelerator Engine IC product family is based on the company's patented high-performance, high-density random-access memory and its highly efficient, high speed GigaChip serial-interface technology, and incorporates powerful application accelerating in-memory compute functions. For more information, visit the company's website at www.mosys.com

Motorcar Parts of America Inc. (NASDAQ: MPAA)

Motorcar Parts of America (NASDAQ: MPAA) is a remanufacturer, manufacturer and distributor of automotive aftermarket parts -- including alternators, starters, wheel bearing and hub assemblies, brake calipers, brake master cylinders, brake power boosters, rotors, brake pads and turbochargers utilized in imported and domestic passenger vehicles, light trucks and heavy-duty applications. In addition, the company designs and manufactures test solutions for performance, endurance and production testing of electric motors, inverters, alternators, starters and belt starter generators for the OE, aerospace and aftermarket. Motorcar Parts of America's products are sold to automotive retail outlets and the professional repair market throughout the United States and Canada. For more information, visit the company's website at www.motorcarparts.com

MTBC Inc. (NASDAQ: MTBC)

MTBC (NASDAQ: MTBC) is a health care information technology solution provider that offers hospitals and physician practices a comprehensive product portfolio of fully integrated clinical, revenue cycle and practice management solutions and other related business services including transcription and data management. MTBC's entire product portfolio - along with native mobile applications - functions as a cohesive, single-database platform to help healthcare providers improve their financial performance and ultimately transform their medical practice into a successful business enterprise. MTBC serves a wide array of healthcare entities across the healthcare continuum - from single physician, medium-sized practices to independent physician associations. For more information, visit the company's website at www.mtbc.com

Myomo Inc. (NYSE: MYO)

Myomo (NYSE: MYO) is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living. For more information, visit the company's website at www.myomo.com

NAPCO Security Technologies Inc. (NASDAQ: NSSC)

NAPCO Security Technologies (NASDAQ: NSSC) is one of the world's leading solutions providers and manufacturers of high technology electronic security, IoT connected home, video, fire alarm, access control and door locking systems. The company consists of four divisions: NAPCO, its security and IoT connected home segment, plus three wholly owned subsidiaries: Alarm Lock, Continental Instruments and Marks USA. NAPCO products are installed by tens of thousands of security professionals worldwide in commercial, industrial, institutional, residential and government applications. NAPCO products have earned a reputation for innovation, technical excellence and reliability, positioning the company for growth in the multi-billion dollar and rapidly expanding electronic security market. For more information, visit the company's website at www.napcosecurity.com

Natus Medical Inc. (NASDAQ: NTUS)

Natus Medical (NASDAQ: NTUS) is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company offers medical equipment, software, supplies and services for the diagnosis, monitoring and treatment of impairments and disorders affecting newborns, the brain, nerves, muscles, balance, mobility and hearing. The company's comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. The company's products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world. For more information, visit the company's website at www.natus.com

Neogen Corp. (NASDAQ: NEOG)

Neogen (NASDAQ: NEOG) develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants. For more information, visit the company's website at www.neogen.com

Nesco Holdings Inc. (NYSE: NSCO)

Nesco Holdings (NYSE: NSCO) is one of the largest providers of specialty equipment, parts, tools, accessories and services to the electric utility transmission and distribution, telecommunications and rail markets in North America. Nesco offers its specialized equipment to a diverse customer base for the maintenance, repair, upgrade and installation of critical infrastructure assets including electric lines, telecommunications networks and rail systems. Nesco's coast-to-coast rental fleet of more than 4,300 units includes aerial devices, boom trucks, cranes, digger derricks, pressure drills, stringing gear, hi-rail equipment, repair parts, tools and accessories. For more information, visit the company's website at www.nescospecialty.com

Netlist Inc. (OTCQX: NLST)

Netlist (OTCQX: NLST) provides high-performance SSDs and modular memory subsystems to enterprise customers in diverse industries. HybriDIMM, Netlist's next-generation storage class memory product, addresses the growing need for real-time analytics in Big Data applications, in-memory databases, high-performance computing and advanced data storage solutions. Netlist also manufactures and provides a line of specialty and legacy memory products to storage customers, appliance customers, system builders and cloud and datacenter customers. Netlist holds a portfolio of patents, many seminal, in the areas of hybrid memory, storage class memory, rank multiplication and load reduction. For more information, visit the company's website at www.netlist.com

New Age Beverages Corp. (NASDAQ: NBEV)

New Age Beverages (NASDADQ: NBEV) is a Colorado-based healthy products company dedicated to inspiring and educating consumers to "live healthy." The company is the only omni-channel company with access to traditional retail, e-commerce, direct-to-consumer, and medical channels across 60 countries around the world. NewAge is also the only one-stop-shop of healthy beverages and includes the brands Nestea, Illy Coffee, Volvic, Evian, Tahitian Noni, TeMana, Búcha Live Kombucha, Marley, and others. NewAge competes in the growth segments of the >$1 trillion-dollar non-alcoholic beverage industry and has become one of the largest non-alcoholic healthy beverage companies in the world. For more information, visit the company's website at www.newagebev.com

New Pacific Metals Corp. (TSXV: NUAG) (OTCQX: NUPMF)

New Pacific Metals (TSXV: NUAG) (OTCQX: NUPMF) is a Canadian Mining Issuer in the business of exploring and developing precious metal mining properties in Bolivia, Canada and China. The company's flagship project is the Silver Sand project in the Potosí Department of Bolivia. The largest shareholders are Silvercorp Metals Inc. (TSX/NYSE American: SVM), the largest primary silver producer in China, and Pan American Silver Corp. (TSX/NASDAQ: PAAS), one of the world's largest primary silver producers, which operates six mines, including the San Vicente mine located in the Potosí Department of Bolivia. For more information, visit the company's website at www.newpacificmetals.com

Newtek Business Services Corp. (NASDAQ: NEWT)

Newtek Business Services (NASDAQ: NEWT) is an internally managed, non-diversified, closed-end management investment company. Along with its wholly owned subsidiary and controlled portfolio companies, Newtek provides a wide range of business and financial solutions under the Newtek® brand to the small- and medium-sized business market. Newtek's products and services include: Business Lending including SBA 7(a) loans, 504 loans and conventional loans, Electronic Payment Processing, Managed Technology Solutions (Cloud Computing), Technology Consulting, eCommerce, Accounts Receivable and Inventory Financing, personal and commercial lines Insurance Services, Web Services, Data Backup, Storage and Retrieval, and Payroll and Benefits Solutions to small- and medium-sized business relationships nationwide across all industries. For more information, visit the company's website at www.newtekone.com

Northern Oil and Gas Inc. (NYSE: NOG)

Northern Oil and Gas (NYSE: NOG) is an exploration and production company with a core area of focus in the Williston Basin Bakken and Three Forks play in North Dakota and Montana. The company is a leading non-operator franchise in the Bakken and Three Forks plays in the Williston Basin of North Dakota and Montana. The foundation of the company's success is the long-term relationships it has built in the Williston Basin with premier operators and landowners. Northern has targeted areas in the Williston Basin where activity levels are the highest and offers the highest rates of return on oil drilling projects. For more information, visit the company's website at www.NorthernOil.com

NV5 Global Inc. (NASDAQ: NVEE)

NV5 Global (NASDAQ: NVEE) is a leading provider of professional and technical engineering and consulting solutions for public and private sector clients in the infrastructure, construction, real estate and environmental markets. The company primarily focuses on five business verticals: construction quality assurance, infrastructure, energy, program management and environmental. NV5 operates out of more than 100 offices nationwide and abroad. For more information, visit the company's website at www.nv5.com

Ocugen Inc. (NASDAQ: OCGN)

Ocugen (NASDAQ: OCGN) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye. The company's phase 3 small molecule drug candidate for oGVHD, if approved, will be the first and only treatment for this orphan disease. Ocugen's breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – "one to many." And the company's novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. For more information, visit the company's website at www.ocugen.com

OMNIQ Corp. (OTC: OMQS)

OMNIQ (OTC: OMQS) operates two divisions, HTS Image Processing and Quest Solution. HTS Image Processing is a leading provider of computer vision image processing-based solutions using patented and proprietary AI technology to provide real-time surveillance and monitoring for homeland security, traffic & parking management, law enforcement and access control applications, as well as supply chain management. Quest Solution provides supply chain solutions, specializing in the design, deployment and management of enterprise mobility solutions. The company's mobility products and services offering is designed to identify, track, trace, share and connect data to enterprise systems such as CRM or ERP solutions. OMNIQ's customers cover a broad spectrum of leading Fortune 500 companies. For more information, visit the company's website at www.questsolution.com

Oncolytics Biotech Inc. (NASDAQ: ONCY)

Oncolytics Biotech (NASDAQ: ONCY) is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumor lysis and promotes an inflamed tumor phenotype - turning "cold" tumors "hot" - through innate and adaptive immune responses to treat a variety of cancers. Pelareorep has demonstrated synergies with immune checkpoint inhibitors and may also be synergistic with other approved immuno-oncology agents. Oncolytics is currently conducting and planning additional studies in combination with checkpoint inhibitors and targeted therapies in solid and hematological malignancies, as it prepares for a phase 3 registration study in metastatic breast cancer. For more information, visit the company's website at www.oncolyticsbiotech.com

OncoSec Medical Inc. (NASDAQ: ONCS)

OncoSec Medical (NASDAQ: ONCS) is a late-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead immunotherapy investigational product candidate, TAVO, enables the intratumoral delivery of DNA-based interleukin-12 (IL-12), a naturally occurring protein with immune-stimulating functions. OncoSec has built a deep and diverse clinical pipeline utilizing TAVO as a potential treatment for multiple cancer indications either as a monotherapy or in combination with leading checkpoint inhibitors. Results from recently completed clinical studies of TAVO have demonstrated a local immune response, and subsequently, a systemic effect as either a monotherapy or combination treatment approach. For more information, visit the company's website at www.oncosec.com

One Stop Systems Inc. (NASDAQ: OSS)

One Stop Systems (NASDAQ: OSS) designs and manufactures innovative specialized ultra-high-performance computing building blocks and platforms for OEMs that provide edge systems to scientists, engineers, creators and other professionals for their mission critical applications. These specialized platforms include customized servers, compute accelerators, flash storage arrays, expansion systems and storage software. The products are used for deep learning, AI, defense, finance and entertainment applications. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe flash cards to build award-winning systems, including many industry firsts, for OEMs and government customers. For more information, visit the company's website at www.onestopsystems.com

Ooma Inc. (NYSE: OOMA)

Ooma (NYSE: OOMA) creates powerful connected experiences for businesses and consumers, delivered from its smart cloud-based SaaS platform. For businesses of all sizes, Ooma provides advanced voice and collaboration features that are flexible and scalable. For consumers, Ooma's residential phone service provides PureVoice HD voice quality, advanced functionality and integration with mobile devices. Ooma's innovative smart security solution delivers a range of wireless security sensors that make it easy for anyone to protect their home or business. For more information, visit the company's website at www.ooma.com

OptimizeRx Corp. (NASDAQ: OPRX)

OptimizeRx (NASDAQ: OPRX) connects pharmaceutical companies to patients and providers, offering greater affordability, adherence and brand awareness at the point-of-care. As the nation's largest digital platform connecting life sciences to the point-of-care, OptimizeRx provides a direct channel for pharma companies, payers, medtech, medical associations to communicate with healthcare providers right within their workflow and directly to patients. The cloud-based solution supports patient adherence to medications and better outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms via its mobile communications platform and digital therapeutics SaaS platform. For more information, visit the company's website at www.OptimizeRx.com

Oragenics Inc. (NYSE: OGEN)

Oragenics (NYSE: OGEN) is focused on becoming a leader in developing effective treatments for oral mucositis and novel antibiotics against infectious disease. Oragenics has established two exclusive worldwide channel collaborations with Precigen (formerly known as Intrexon Corporation) and its subsidiaries. The collaborations allow Oragenics to accelerate the development of biotherapeutics for oral mucositis and other diseases and conditions of the oral cavity, throat and esophagus and much needed new antibiotics that can work against resistant strains of bacteria. For more information, visit the company's website at www.oragenics.com

Ormat Technologies Inc. (NYSE: ORA)

Ormat Technologies (NYSE: ORA) owns, operates, designs, manufactures and sells geothermal and recovered energy generation (REG) power plants primarily based on the Ormat Energy Converter – a power generation unit that converts low-, medium- and high-temperature heat into electricity. With 77 U.S. patents, Ormat's power solutions have been refined and perfected under the most grueling environmental conditions. Ormat has 584 employees in the United States and 762 overseas. Ormat's flexible, modular solutions for geothermal power and REG are ideal for vast range of resource characteristics. The company has engineered, manufactured and constructed power plants, which it currently owns or has installed to utilities and developers worldwide, totaling over 2,900 MW of gross capacity. For more information, visit the company's website at www.ormat.com

OSI Systems Inc. (NASDAQ: OSIS)

OSI Systems (NASDAQ: OSIS) is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information, visit the company's website at www.osi-systems.com

Let's get started.

Interested in a live, online demonstration? Schedule a date and time that works for you.

Schedule a LIVE Demo

Questions about IBN and our solutions? Call or send us an email.

(310) 299-1717